CORDIS
EU research results

CORDIS

English EN
Biomaterials and Additive Manufacturing: Osteochondral Scaffold innovation applied to osteoarthritis

Biomaterials and Additive Manufacturing: Osteochondral Scaffold innovation applied to osteoarthritis

Objective

Osteoarthritis (OA) is a degenerative joint disease, typified by a loss of quality of cartilage and changes in bone at the interface of a joint, resulting in pain, stiffness and reduced mobility. BAMOS project particularly addresses the challenges in OA treatment by providing novel cost effective osteochondral scaffold technology for early intervention of OA to delay or avoid the joint replacement operations. This project has the potential to relieve pain in patients with OA improving their quality of life by keeping people active. It fits with the scope of EU Societal Changellenges to encourage the provision of improved clinical care for patients in the field of healthcare, especially for elderly patients.
In the course of developing this new treatment for mid- to late stage OA, BAMOS aims to establish and embed a new collaboration between six internationally leading research organisations (four universities, one healthcare provider and one manufacturer with expertise in additive manufacturing). The partners propose an integrated programme of research activities and the development of a collaborative graduate training scheme. The dissemination of research will result in at least 15 high profile joint research publications, and the consortium will organise two international scientific conferences (one in the EU, one in China) and 3 workshops.
BAMOS will develop new materials and manufacturing technologies for the fabrication of custom-tailored osteochondral scaffolds. Novel biopolymeric composites, processed by additive manufacturing, will be characterized and tested as well as coatings on titanium scaffolds. Also, thermal welding technique will be used to join the cartilage component with the bone component to form an osteochondral unit.
The new technologies will undergo full pre-clinical evaluation in order that the scaffolds are able to enter clinical trial after the project.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

UNIVERSIDAD DE LAS PALMAS DE GRAN CANARIA

Address

C/ Juan De Quesada 30
35001 Las Palmas De Gran Canaria

Spain

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 225 000

Participants (3)

Sort alphabetically

Sort by EU Contribution

Expand all

UNIVERSITY COLLEGE LONDON

United Kingdom

EU Contribution

€ 180 000

UNIVERSIDADE DO MINHO

Portugal

EU Contribution

€ 166 500

THE ROYAL NATIONAL ORTHOPAEDIC HOSPITAL NATIONAL HEALTH SERVICE TRUST

United Kingdom

EU Contribution

€ 67 500

Partners (3)

Sort alphabetically

Expand all

XI'AN JIAOTONG UNIVERSITY

SHAANXI HENGTONG INTELLIGENT MACHINE CO LTD

Zhejiang University

Project information

Grant agreement ID: 734156

Status

Ongoing project

  • Start date

    1 January 2017

  • End date

    31 December 2020

Funded under:

H2020-EU.1.3.3.

  • Overall budget:

    € 774 000

  • EU contribution

    € 639 000

Coordinated by:

UNIVERSIDAD DE LAS PALMAS DE GRAN CANARIA

Spain